Psilocybin, a psychoactive compound found in magic mushrooms, is approved in Australia for use in treatment-resistant depression.But a new study suggests the benefits of psilocybin in these patients might not be as effective as past clinical trials have suggested.In 2023, Australia became the first country in the world to legalise the use of psychedelics to treat some mental health conditions.Guest/sAssociate Professor Fredrik Hieronymus, Group leader of the clinical psychopharmacology group, University of GottenburgReferencesControl Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related